ArticleFrontiers in oncology2022

Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model.

Maria Vitale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.